Cultural Adaptation of the Female Pelvic Floor Questionnaire (FPFQ) Into French

Affiliation auteurs!!!! Error affiliation !!!!
TitreCultural Adaptation of the Female Pelvic Floor Questionnaire (FPFQ) Into French
Type de publicationJournal Article
Year of Publication2017
AuteursDeparis J, Bonniaud V, Desseauve D, Guilhot J, Masanovic M, De Tayrac R, Fauconnier A, Fritel X
JournalNEUROUROLOGY AND URODYNAMICS
Volume36
Pagination253-258
Date PublishedFEB
Type of ArticleArticle
ISSN0733-2467
Mots-clésFrench, pelvic floor, Questionnaire, Symptoms, validation studies
Résumé

Aims: The Female pelvic floor questionnaire ( FPFQ) is a self-administered tool on pelvic floor function. Our aim was to carry out a cultural adaptation of the FPFQ into French and to assess its psychometric properties. Methods: After cross-cultural adaptation into French, acceptability and reliability of the questionnaire were assessed through a sample of 56 women in a test-retest. Discriminative construct validity was evaluated by comparing the results obtained by the FPFQ to those of other validated questionnaires. Longitudinal follow-up of the 282 pregnant women included in the PreNatal Pelvic floor Prevention trial ( 3PN) was used to analyze responsiveness. Results: The proportion of missing data did not exceed 4% for questions about bladder function, bowel function, and pelvic organ prolapse; 10% for issues related to sexual function. Question 9 was considered difficult to understand by 14% of women. After rewriting, this issue was retested in a new sample of 52 women and presented no further problems. The intra-class correlation coefficient was greater than or equal to 0.7 for all domains during the test-retest. The FPFQ was strongly and significantly correlated ( Spearman r>0.5) with the other validated questionnaires. The French version of FPFQ recorded changes in urinary and sexual symptoms for the women involved in 3PN trial with a standardized response mean equal to 0.83 and 0.44, respectively. Conclusion: The French version of the FPFQ is self-administered, reliable, valid, and can detect a change in symptoms during follow-up. (C) 2015 Wiley Periodicals, Inc.

DOI10.1002/nau.22932